By Northern blot analysis using a cDNA clone of the perforin gene, w e studied the levels of perforin mRNA in peripheral blood mononuclear cells from 11 cases of granular lymphocyte-proliferative disorders (GLPDs). The granular lymphocytes studied were characterized by morphologic, immunophenotypic, and immunogenotypic analyses. Cytolytic functions of the lymphocytes assayed included nonmajor histocompatibility complex-requiring cytotoxicity, anti-CD3-redirected cytotoxicity, antibodydependent cellular cytotoxicity, and lectin-dependent cellular cytotoxicity. The results showed that in lymphocytes with strong cytolytic functions high levels of perforin GROUP OF disorders, collectively termed granular A lymphocyte-proliferative disorders (GLPDs),' chronic Ty-lymphoproliferative disease,* or large granular lymphocyte l e~k e m i a ,~ is characterized by the proliferation of granular lymphocytes (GLs), ie, lymphocytes with azurophilic granules in the cytoplasm. GLPDs of the CD3+4-8+ phenotype and CD3-16+ phenotype are common, whereas those of CD3+4-8-and CD3+4+8-are rare. Proliferating GLs sometimes exhibit nonmajor histocompatibility complex (MHC)-requiring cytotoxicity, antibody-dependent cellular cytotoxicity (ADCC), or lectin-dependent cellular cytotoxicity (LDCC). Furthermore, CD3+WT31+ GLs exhibit cytotoxicity for immunoglobulin G Fc receptor-positive target cells when anti-CD3 monoclonal antibody (MoAb) or WT31 MoAb is added during the cytotoxicity assay.4 The mechanisms of cytolysis observed in these GLs have not been studied, however.
mRNA existed, whereas in lymphocytes with weak or undetectable levels of cytolytic functions, low levels of perforin mRNA existed. Because the levels of perforin mRNA correlated with those of cytolytic functions, perforin is probably a mediator in cytolytic functions of granular lymphocytes in patients with GLPDs. When the lymphocytes were cultured for 1 day, however, the levels of cytolytic activity were increased, and those of perforin mRNA were decreased. Therefore, we cannot rule out the possibility that factors other than perforin protein are involved in the cytolytic functions of granular lymphocytes. 0 1990 by The American Society of Hematology.
patients for more than 6 months. GLs were defined as lymphocytes with three or more azurophilic granules in the cytoplasm, irrespective of their cell size. ' PBMNCs isolated by Ficoll-Conray were stained by indirect immunofluorescence with the following antibodies: OKT3 (anti-CD3), OKT4 (anti-CD4), and OKT8 (anti-CD8) from Dr G. Goldstein, Ortho, Raritan, NJ; WT31 (which may react with T-cell antigen receptor (TCR)".'2) from Sanbio, Uden, the Netherlands; and CLB FcR gran 1 (anti-CD16) from Dr P. A. T. Tetteroo, the Netherlands Red Cross, Amsterdam. Stained cells were analyzed in a cell sorter as described previously."
Immunogenotypic analysis of TCR-(3 gene rearrangements was performed by Drs Y. Kobayashi and F. Ishikawa at the Department of Medicine, University of Tokyo Faculty of Medicine, as described previo~sly.4~'~ The method of cytotoxic assay is described el~ewhere.4~"~'~ PBMNCs 1 x IO5 were incubated, in triplicate, with 5 x IO3 5'Cr-labeled target cells for 5 hours, after which the supernatant was harvested and the specific "Cr release calculated according to the formula: percentage of release = [(experimental 5'Cr release -spontaneous 5'Cr release)/(maximum 5'Cr release -spontaneous "Cr release)] x 100. Anti-CD3 MoAb OKT3
(1 pg/mL) and WT31 MoAb (IOpg/mL) were added 1 hour before the "Cr-release assay was started.
To assay ADCC, heat-inactivated rabbit anti-P815 serum was added at a final dilution of 1:900 to 5'Cr-labeled P815 target cells in the cytotoxicity assay. LDCC was assayed against S'Cr-labeled P8 15 or K562 target cells, after addition of 1 :9,000-diluted phytohemagglutinin (PHA)-P (GIBCO, Grand Island, NY). Because anti-CD3 and WT31 MoAbs induced non-MHCrequiring cytotoxicity for IgG Fc receptor-bearing targets in patient PBMNCs after 1-day incubation of PMBNCs; cytotoxicity assays were performed using freshly isolated PBMNCs and after 1-day incubation of PBMNCs in RPMI 1640 medium with 10% fetal calf serum (FCS) in microculture plates.
Cytolytic functions and expression of perforin mRNA were studied in normal CD3-16+ NK cells and CD3+16-cells. These cells were isolated by Percoll density-gradient centrifugation followed by negative selection with the panning method, as described p r e v i o~s l y .~~'~ The isolated CD3-16+ NK fraction from a donor contained 97% GLs, 95% CD16' cells, and 4% CD3+ cells. The isolated CD3+16-T-cell fraction contained 3% GLs, 5% CD16' cells, and 97% CD3+ cells. (1 x IO8 dpmlpg, 2.5 x IO5 dpm/mL) 32P-labeled by the T3 RNA transcription system (Stratagene Cloning Systems, La Jolla, CA). After hybridization, the blot was washed four times in 0.1 x SSPE, 0.1% SDS at 65OC for 1 hour. The blots were exposed to Kodak XAR-5 film with an intensifying screen at -7OoC for 2 to 7 days. In some experiments, hybridized filters were rewashed for 30 minutes at room temperature in 2 x SSPE containing 1 pg/mL RNase A and washed twice for 15 minutes at 65OC in 0.1 x SSPE, 0.1% SDS.
The human perforin probe" consisted of a 2.1-kilobase (kb) fragment containing the coding sequence of human perforin cDNA of the clone YT-I 32 in a Bluescript plasmid (Stratagene). Riboprobe was synthesized from YT-132 linearized with EcoRV by T3 RNA polymerase with CT-~*P-UTP (3,000 Ci/mmol).
Because the cytolytic functions were assayed in terms of lymphocyte number, the levels of perforin mRNA were also assayed in terms of lymphocyte number. Determination of ribosomal RNA showed no substantial loss of RNA contents during the procedure.
RESULTS

In 7
of the 11 patients with GLPDs, the clinical features and PBMNC surface phenotypes have been described previo~sly.'.~,'~ As shown in Table 1 , the GL percentages in PBMNCs were high, ranging from 73% to 98%. Phenotypic markers of GLs were CD3+4-8+16+ in 6 patients, CD3'4-8-16+ in one, CD3+4+8-16+ in 1, and CD3-4-8-16+ in 3. The TCR-@ gene was monoclonally rearranged in most patients with CD3+ GLPDs and was in germline configuration in CD3-GLPDs. Non-MHCrequiring cytotoxicity of freshly isolated PBMNCs was either high or low and in CD3+ GLPDs was either enhanced or inhibited by addition of anti-CD3 and/or WT31 MoAbs. Most patients had ADCC and LDCC.
As controls, 1 patient with CD3+4+8-adult T-cell leuke-
Patient characteristics and PBMNC cytotoxicity.
mia (ATL), 2 patients with CDlO+ 19+20+ acute lymphoblastic leukemia (ALL), and 1 normal individual were included. In these patients, more than 80% of PBMNCs were leukemic cells, and 52% were GLs. In one patient with ALL, 47% of PB lymphoblasts contained several prominent azurophilic granules in the cytoplasm. PBMNCs of the three leukemia patients exhibited less than 5% of specific "Cr release in cytolytic assays (data not shown). CD3-16+ NK cells of the normal donor exhibited strong non-MHC requiring ADCC and LDCC cytotoxicity (Table 1) . Figure 1 shows the results of Northern blot analysis of cytoplasmic RNA extracted from freshly isolated PBMNCs of the populations studied. In PBMNCs from patients with GLPDs, a single region of hybridization was detected with the perforin probe at approximately 3 kb; the level of expression differed from patient to patient. In PBMNCs from patients with ATL and ALL, perforin mRNA was rarely detected. In cells from a normal individual, low levels of perforin mRNA were detected in whole PBMNCs and the CD3+16-T-cell fraction and a high level of mRNA was detected in the CD3-16+ NK fraction. On the whole, the data indicate that PBMNCs lacking GLs rarely expressed perforin mRNA whereas PBMNCs containing GLs expressed perforin mRNA. The levels of perforin mRNA did not correlate with the percentage of GLs, however; instead they correlated with the highest level of cytotoxicity obtained.
PBMNC cytotoxicity and perforin mRNA after I-day incubation of PBMNCs. Because we previously showed that GL cytolytic functions were significantly enhanced by 1-day preincubation of GLs?I4 we incubated PBMNCs of some patients for 1 day in RPMI 1640 medium containing 10% FCS and examined their cytolytic functions and perforin mRNA levels. As expected, the cytolytic functions were enhanced in all patients tested (Table 2) , whereas the levels Northern blot analysis of perforin gene expression. $Levels of cytotoxicity of freshly iwlated PBMNCs are expressed as -(O% to 9%). + (10% to 29%). + + (30% to 49%). + + + (50% to 69%). and + + + + (70% to $From a normal individual, whole PBMNCs, CD3-16' NK cells, and CD3'16-T lymphocytes were isolated and their cytotoxicity was assayed. 100%) at an effector-to-target ratio of 20:l. a-CD3 denotes antLCD3 MoAb treatment. of perforin mRNA were decreased in five of six patients tested (Fig 2) . In patient 6. perforin mRNA level was increased. These results strongly suggest that perforin mRNA and perforin protein are located mainly. i f not exclusively, in GLs. In a few GLPD patients (patients 6.8. and 9) and an A L L patient with azurophilic granules in lymphoblasts (patient 13). however. thc high SL percentages were accompanied by low levels of perforin mRNA. suggesting the existence of GLs containing only minimal. if any. perforin mRNA and perforin protein. Furthermore. in these patients. the levels of PRMNC cytotoxicity were low. Together. the levels of perforin mRNA correlated with those of PRMNC cytolytic functions rather than with G L percentages in PRMNCs. Pcrforin mRNA level. therefore. appears to be a good indicator for detection of levels of cytolytic functions. In this study. cytolytic activities were induced by various procedures ( Table I ) . DifTcrent levels of cytotoxicity were induced according to the methods used, and the levels of cytotoxicity d i f T c d from patient to patient. The degree of
No. cytotoxicity may be reflected by different factors. including the level of cytolytic molecules."" Recause the factor at the lowest level will limit cytolytic functions. the highest level of cytotoxicity observed in a particular patient implies at least such a level of cytolytic molecules in elfector lymphocytes. Thus, the correlation between the highest levels of cytotoxicity and the levels of pcrforin mRNA can be explained by the hypothesis that pcrforin protein is a mediator for patient PRMYC cytolytic functions. When the patient PRMNCs were cultured for 1 day. however, the levels of cytotoxicity were enhanced and those of pcrforin mRNA were decreased. As recently reported by Lichtenheld et al.'" interleukin 2 (Il,-2)-induced pcrforin m R N A expression and Il-2-induced lymphokine-activated killer ( L A K ) cell activity do not move in parallel; the peak of LAK activity was observed 12 hours later than that of pcrforin mRWA expression. and high levels of pcrforin appeared to be maintained even when pcrforin mRNA had decreased to a lower stcady-state level. This indicates that the reduced expression of pcrforin mRNA in our culture system docs not always imply a lower level of pcrforin protein contents. Recause changes in the amounts of pcrforin protein in a few cells cannot be monitored. we cannot rule out the possibility of enhanced levels of pcrforin protein in our I-day incubated PRMNCs. Sulica et al" and ltoh et aIm reported that N K activity of normal individuals and GL cytotoxicity of a patient with GLPD were enhanced simply by incubation of the cells. and this enhancement was considered to result from removal of inhibitory IgG present on the cell surface" or in the serum3 after in vitro culture. Therefore. the same phenomenon probably occurred in our culture system. Another possibility that a pcrforin-indepcndent killing pathway was involved cannot be ruled out bccause this finding has recently been reported in CTLs.'."?'.-':-':
The decrease in pcrforin mRWA levels after incubation can be explained if IL-2 is responsible for pcrforin mRNA expression as has been reported by other investigators"'and if the expression of pcrforin mRNA in GLs depcnds on IL-2 present in the serum. Deprivation of 11,-2 in culture conditions may therefore decrease pcrforin mR%A levels. In patient 6. however. incubation of PRMNCs enhanced the pcrforin mRNA level. PRMNCs of this patient were heterogeneous in surface phcnotypcs and contained a greater number of CD4' cells than did those of the other patients 
